AZD1390 FOR RECURRENT GLIOBLASTOMA
A Phase 0/1b clinical trial to evaluate AZD1390 in patients with recurrent glioblastoma.
Talk to an Ivy Navigator
602-406-8605A Phase 0/1b clinical trial to evaluate AZD1390 in patients with recurrent glioblastoma.